Dimethylphenylpiperazinium
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 1,1-dimethyl-4-phenylpiperazin-1-ium | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 114-28-3  |
| ATC code | ? |
| PubChem | CID 1316 |
| ChemSpider | 1276  |
| ChEMBL | CHEMBL134752 |
| Chemical data | |
| Formula | C12H19N2 |
| Mol. mass | 191.29 g/mol |
| SMILES | eMolecules & PubChem |
|
|
 (what is this?) (verify) |
Dimethylphenylpiperazinium (DMPP) is a nicotinic acetylcholine receptor agonist which is selective for the ganglionic subtype.[1]
[edit] See also
[edit] References
- ^ Prado WA, Segalla DK (August 2004). "Antinociceptive effects of bethanechol or dimethylphenylpiperazinium in models of phasic or incisional pain in rats". Brain Res. 1018 (2): 272–82. doi:10.1016/j.brainres.2004.05.085. PMID 15276888. http://linkinghub.elsevier.com/retrieve/pii/S0006899304008923.
|
|
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
